Coherus Biosciences(CHRS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CHRS Coherus Biosciences

休市中 06-14 16:00:00 EDT

1.69

-0.09

-5.06%

盘后1.68

-0.01-0.59%

19:17 EDT

最高1.75	最低1.66	成交量186.55万
今开1.72	昨收1.78	日振幅5.06%
总市值1.94亿	流通市值1.63亿	总股本1.15亿
成交额316.75万	换手率1.93%	流通股本9,659万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CHRS","market":"US","secType":"STK","nameCN":"Coherus Biosciences","latestPrice":1.69,"timestamp":1718395200000,"preClose":1.78,"halted":0,"volume":1865532,"hourTrading":{"tag":"盘后","latestPrice":1.68,"preClose":1.69,"latestTime":"19:17 EDT","volume":497637,"amount":841036.6482,"timestamp":1718407030116},"delay":0,"floatShares":96594954,"shares":114725740,"eps":-0.578234,"marketStatus":"休市中","marketStatusCode":7,"change":-0.09,"latestTime":"06-14 16:00:00 EDT","open":1.72,"high":1.75,"low":1.66,"amount":3167484.3576084003,"amplitude":0.050562,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.578234,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1718611200000},"adr":0,"listingDate":1415250000000,"adjPreClose":1.78,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.74,"preClose":1.78,"latestTime":"09:11 EDT","volume":961,"amount":1678.9399399000001,"timestamp":1718370707362},"postHourTrading":{"tag":"盘后","latestPrice":1.68,"preClose":1.69,"latestTime":"19:17 EDT","volume":497637,"amount":841036.6482,"timestamp":1718407030116},"volumeRatio":1.6591476390009736,"impliedVol":4.4115,"impliedVolPercentile":0.9881},"requestUrl":"/m/hq/s/CHRS/tweets","defaultTab":"tweets","newsList":[{"id":"2443672536","title":"Coherus Biosciences, Inc.盘中异动 早盘股价大跌5.90%报1.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443672536","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443672536?lang=zh_cn&edition=full","pubTime":"2024-06-14 23:26","pubTimestamp":1718378762,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日23时26分，Coherus Biosciences, Inc.股票出现波动，股价快速下挫5.90%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614232602941eeb32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614232602941eeb32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4139","BK4535"],"gpt_icon":0},{"id":"2442312557","title":"Coherus Biosciences, Inc.盘中异动 早盘大幅拉升6.07%报1.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442312557","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442312557?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:31","pubTimestamp":1718199077,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时31分，Coherus Biosciences, Inc.股票出现异动，股价大幅上涨6.07%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213117941ee09b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213117941ee09b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CHRS","BK4535"],"gpt_icon":0},{"id":"2438601250","title":"Coherus Biosciences, Inc.盘中异动 临近收盘股价大跌5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2438601250","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438601250?lang=zh_cn&edition=full","pubTime":"2024-05-25 03:52","pubTimestamp":1716580363,"startTime":"0","endTime":"0","summary":"北京时间2024年05月25日03时52分，Coherus Biosciences, Inc.股票出现异动，股价大幅跳水5.47%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。该信息摘要如下：HC Wainwright & Co.：重申Coherus BioSciences评级，由买入调整至买入评级, 目标价12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240525035243af8a31a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240525035243af8a31a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4535","BK4139"],"gpt_icon":0},{"id":"2437750766","title":"Coherus Biosciences, Inc.盘中异动 早盘急速下挫5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437750766","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437750766?lang=zh_cn&edition=full","pubTime":"2024-05-23 21:45","pubTimestamp":1716471914,"startTime":"0","endTime":"0","summary":"北京时间2024年05月23日21时45分，Coherus Biosciences, Inc.股票出现波动，股价急速下跌5.18%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240523214515aef1573c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240523214515aef1573c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CHRS","BK4535"],"gpt_icon":0},{"id":"2436181658","title":"Coherus Biosciences, Inc.2024财年第一财季实现净利润1.03亿美元，同比增加236.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436181658","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436181658?lang=zh_cn&edition=full","pubTime":"2024-05-19 00:17","pubTimestamp":1716049071,"startTime":"0","endTime":"0","summary":"3月31日，Coherus Biosciences, Inc.公布财报，公告显示公司2024财年第一财季净利润为1.03亿美元，同比增加236.01%；其中营业收入为77.06百万美元，同比增加137.55%，每股基本收益为0.91美元。机构评级：截至2024年3月31日，当前有6家机构对Coherus Biosciences, Inc.目标价做出预测，其中目标均价为8.33美元，其中最低目标价为4.00美元，最高目标价为12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405190017548b15ec87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405190017548b15ec87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS"],"gpt_icon":0},{"id":"2435613373","title":"Coherus Biosciences, Inc.盘中异动 股价大涨5.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435613373","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435613373?lang=zh_cn&edition=full","pubTime":"2024-05-13 21:31","pubTimestamp":1715607118,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日21时31分，Coherus Biosciences, Inc.股票出现波动，股价急速上涨5.79%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.99%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。该信息摘要如下：Truist Securities：维持Coherus BioSciences评级，由买入调整至买入评级, 目标价由8.00美元调整至7.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051321315879275fe7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051321315879275fe7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","CHRS","BK4139"],"gpt_icon":0},{"id":"2435918327","title":"Truist Securities：维持Coherus BioSciences(CHRS.US)评级，由买入调整至买入评级, 目标价由8.00美元调整至7.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435918327","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435918327?lang=zh_cn&edition=full","pubTime":"2024-05-13 20:26","pubTimestamp":1715603202,"startTime":"0","endTime":"0","summary":"Truist Securities：维持Coherus BioSciences(CHRS.US)评级，由买入调整至买入评级, 目标价由8.00美元调整至7.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132026458b016ff2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132026458b016ff2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS"],"gpt_icon":0},{"id":"2434085103","title":"Coherus Biosciences, Inc.盘中异动 早盘大幅下跌9.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434085103","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434085103?lang=zh_cn&edition=full","pubTime":"2024-05-10 21:30","pubTimestamp":1715347846,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日21时30分，Coherus Biosciences, Inc.股票出现波动，股价大幅下挫9.43%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.97%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051021304687e87193&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051021304687e87193&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4139","BK4535"],"gpt_icon":0},{"id":"2434711026","title":"Coherus BioSciences Inc 报告截至三月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2434711026","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434711026?lang=zh_cn&edition=full","pubTime":"2024-05-10 05:51","pubTimestamp":1715291487,"startTime":"0","endTime":"0","summary":"   * Coherus BioSciences Inc   报告了截至3月底的季度调整后每股亏损32美分，高于去年同期的每股-75美分。六位分析师对该季度的平均预期是每股亏损 24 美分。华尔街预期为每股-37美分至-5美分。* Coherus BioSciences Inc 公布的本季度每股收益为 83 美分。* 公司报告的季度净收入为 1.0288 亿美元。* Coherus BioSciences Inc 的股价本季度下跌了 6.7%，今年迄今为止下跌了 33.0%。5月9日 - 预测变化   * 在过去三个月里，分析师的平均盈利预期下降了约 5.2%。华尔街对 Coherus BioSciences Inc 的 12 个月目标价中位数为 9.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4139","CHRS"],"gpt_icon":0},{"id":"2434046210","title":"Coherus Biosciences, Inc.盘中异动 急速跳水5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434046210","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434046210?lang=zh_cn&edition=full","pubTime":"2024-05-10 02:22","pubTimestamp":1715278943,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日02时22分，Coherus Biosciences, Inc.股票出现波动，股价大幅跳水5.16%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.00%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510022224861ec29a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510022224861ec29a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4535","BK4139"],"gpt_icon":0},{"id":"2433228730","title":"Coherus Biosciences, Inc.盘中异动 下午盘股价大跌5.28%报2.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433228730","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433228730?lang=zh_cn&edition=full","pubTime":"2024-05-07 03:23","pubTimestamp":1715023412,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日03时23分，Coherus Biosciences, Inc.股票出现波动，股价快速下跌5.28%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。该公司在美国销售 Neulasta 的生物仿制药，UDENYCA，并预计于 2023 年在美国推出 FDA 批准的 Humira 生物仿制药 YUSIMRY。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050703233279261206&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050703233279261206&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4139","CHRS"],"gpt_icon":0},{"id":"2432082689","title":"Coherus Biosciences, Inc.盘中异动 大幅上涨5.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432082689","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432082689?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:30","pubTimestamp":1714743048,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时30分，Coherus Biosciences, Inc.股票出现异动，股价大幅拉升5.99%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Vaxxinity, Inc.、Ardelyx, Inc.、Jaguar Health, Inc.涨幅较大，Allarity Therapeutics, Inc.、Vaxxinity, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为57.88%、20.98%、10.03%，振幅较大的相关个股有Relay Therapeutics, Inc.、Rani Therapeutics Holdings, Inc.、Zymeworks Inc.，振幅分别为13.56%、12.87%、6.37%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032130497925c09f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032130497925c09f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4139","CHRS"],"gpt_icon":0},{"id":"2432807975","title":"Coherus BioSciences Inc    预计每股亏损 24 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432807975","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432807975?lang=zh_cn&edition=full","pubTime":"2024-05-03 19:50","pubTimestamp":1714737017,"startTime":"0","endTime":"0","summary":"   * Coherus BioSciences Inc    将于5月9日公布截至2024年3月31日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，6位分析师的平均预期显示，这家总部位于加利福尼亚州红木城的公司的营收将从去年同期的3244万美元增长147.4%，达到8024.8万美元。* LSEG 分析师对 Coherus BioSciences Inc 的平均预期是每股亏损 24 美分。* 华尔街对 Coherus BioSciences Inc 的 12 个月目标价中位数为 9.00 美元，高于其最新收盘价 2.17 美元。5月3日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHRS"],"gpt_icon":0},{"id":"2432329289","title":"Coherus Biosciences, Inc.盘中异动 下午盘急速上涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432329289","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432329289?lang=zh_cn&edition=full","pubTime":"2024-05-03 02:47","pubTimestamp":1714675676,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日02时47分，Coherus Biosciences, Inc.股票出现异动，股价大幅拉升5.22%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.00%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405030247567a57f012&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405030247567a57f012&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4139","CHRS"],"gpt_icon":0},{"id":"2432258638","title":"Coherus Biosciences, Inc.盘中异动 股价大涨5.10%报2.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432258638","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432258638?lang=zh_cn&edition=full","pubTime":"2024-05-02 02:39","pubTimestamp":1714588776,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日02时39分，Coherus Biosciences, Inc.股票出现波动，股价快速上涨5.10%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.52%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405020239367925a48e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405020239367925a48e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4535","BK4139"],"gpt_icon":0},{"id":"2432586420","title":"Coherus Biosciences, Inc.盘中异动 下午盘股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432586420","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432586420?lang=zh_cn&edition=full","pubTime":"2024-05-01 03:06","pubTimestamp":1714503978,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日03时06分，Coherus Biosciences, Inc.股票出现异动，股价急速下跌5.07%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240501030619861ea7c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240501030619861ea7c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CHRS","BK4535"],"gpt_icon":0},{"id":"2430200137","title":"Coherus Biosciences, Inc.盘中异动 快速上涨5.18%报2.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430200137","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430200137?lang=zh_cn&edition=full","pubTime":"2024-04-27 00:11","pubTimestamp":1714147882,"startTime":"0","endTime":"0","summary":"北京时间2024年04月27日00时11分，Coherus Biosciences, Inc.股票出现异动，股价快速上涨5.18%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。该公司在美国销售 Neulasta 的生物仿制药，UDENYCA，并预计于 2023 年在美国推出 FDA 批准的 Humira 生物仿制药 YUSIMRY。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240427001123861e996b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240427001123861e996b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CHRS","BK4535"],"gpt_icon":0},{"id":"2430282776","title":"Coherus Biosciences, Inc.盘中异动 急速下跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430282776","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430282776?lang=zh_cn&edition=full","pubTime":"2024-04-25 22:34","pubTimestamp":1714055688,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日22时34分，Coherus Biosciences, Inc.股票出现异动，股价急速下挫5.20%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.85%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042522344887e83c42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042522344887e83c42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4139","BK4535"],"gpt_icon":0},{"id":"2429197278","title":"Coherus Biosciences, Inc.盘中异动 下午盘大幅上涨5.07%报2.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429197278","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429197278?lang=zh_cn&edition=full","pubTime":"2024-04-23 01:52","pubTimestamp":1713808348,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日01时52分，Coherus Biosciences, Inc.股票出现异动，股价急速拉升5.07%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.97%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404230152297a549e3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404230152297a549e3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CHRS","BK4535"],"gpt_icon":0},{"id":"2428541316","title":"Coherus Biosciences, Inc.盘中异动 股价大跌5.07%报2.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428541316","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428541316?lang=zh_cn&edition=full","pubTime":"2024-04-19 03:37","pubTimestamp":1713469079,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日03时37分，Coherus Biosciences, Inc.股票出现异动，股价快速下跌5.07%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。该公司在美国销售 Neulasta 的生物仿制药，UDENYCA，并预计于 2023 年在美国推出 FDA 批准的 Humira 生物仿制药 YUSIMRY。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190337597a53d1f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190337597a53d1f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4535","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.coherus.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.2248},{"period":"3month","weight":-0.2387},{"period":"6month","weight":-0.2212},{"period":"1year","weight":-0.6865},{"period":"ytd","weight":-0.4925}],"compareEarnings":[{"period":"1week","weight":0.0164},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0646},{"period":"6month","weight":0.1565},{"period":"1year","weight":0.2263},{"period":"ytd","weight":0.1419}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Coherus Biosciences, Inc.于2010年9月在特拉华州注册成立。该公司是一家商业阶段的生物制药公司，专注于创新癌症治疗的研究、开发和商业化以及已获批准的生物类似物组合的商业化。该公司的战略是建立一个领先的免疫肿瘤专营权，其资金来自通过净销售美国食品和药物管理局批准的疗法的多元化组合所产生的现金。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.01531},{"month":2,"riseRate":0.5,"avgChangeRate":0.011849},{"month":3,"riseRate":0.5,"avgChangeRate":0.031914},{"month":4,"riseRate":0.5,"avgChangeRate":-0.06174},{"month":5,"riseRate":0.5,"avgChangeRate":-0.005756},{"month":6,"riseRate":0.4,"avgChangeRate":-0.015679},{"month":7,"riseRate":0.555556,"avgChangeRate":0.108387},{"month":8,"riseRate":0.888889,"avgChangeRate":0.130256},{"month":9,"riseRate":0.111111,"avgChangeRate":-0.131657},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.047713},{"month":11,"riseRate":0.444444,"avgChangeRate":-0.056325},{"month":12,"riseRate":0.5,"avgChangeRate":0.03123}],"exchange":"NASDAQ","name":"Coherus Biosciences","nameEN":"Coherus BioSciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.23.1","shortVersion":"4.23.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Coherus Biosciences(CHRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Coherus Biosciences(CHRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Coherus Biosciences,CHRS,Coherus Biosciences股票,Coherus Biosciences股票老虎,Coherus Biosciences股票老虎国际,Coherus Biosciences行情,Coherus Biosciences股票行情,Coherus Biosciences股价,Coherus Biosciences股市,Coherus Biosciences股票价格,Coherus Biosciences股票交易,Coherus Biosciences股票购买,Coherus Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Coherus Biosciences(CHRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Coherus Biosciences(CHRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}